fda semaglutide warning news october 2025 U.S. | The FDA has approved a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight Semaglutide Patient Safety Updates |

The compound was well tolerated with no evidence of genotoxicity, indicating its potential as a therapeutic agent for type 2 diabetes and obesity in humans

The peptide has four amino acid substitutions in its structure, which scientists suggest may enhance its activity and resistance towards proteolytic enzymes

TeleCare Achieving full physical, mental, and social well-being, beyond just being disease-free

Regulated blood glucose leads to fewer cravings and more stable energy levels

Storage & Handling: Store at -20C for long-term stability Avoid repeated freezethaw cycles Handle using appropriate laboratory PPE Research Handling Note: For best results in a research setting, allow both: the peptide and chosen solvent to reach ambient laboratory temperature before reconstitution

Third-party testing is non-negotiable if youre serious about safety and efficacy